Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health

Interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) are key cytokines that drive the production of inflammatory mediators and matrix-degrading enzymes in osteoarthritis (OA). These proinflammatory cytokines bind to their respective cell surface receptors and activate inflammatory signaling pa...

Full description

Bibliographic Details
Main Authors: Mobasheri, Ali, Henrotin, Yves, Biesalski, Hans-Konrad, Shakibaei, Mehdi
Format: Article
Published: MDPI 2012
Online Access:https://eprints.nottingham.ac.uk/2702/
_version_ 1848790853879857152
author Mobasheri, Ali
Henrotin, Yves
Biesalski, Hans-Konrad
Shakibaei, Mehdi
author_facet Mobasheri, Ali
Henrotin, Yves
Biesalski, Hans-Konrad
Shakibaei, Mehdi
author_sort Mobasheri, Ali
building Nottingham Research Data Repository
collection Online Access
description Interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) are key cytokines that drive the production of inflammatory mediators and matrix-degrading enzymes in osteoarthritis (OA). These proinflammatory cytokines bind to their respective cell surface receptors and activate inflammatory signaling pathways culminating with the activation of nuclear factor κB (NF-κB), a transcription factor that can be triggered by a host of stress-related stimuli including, excessive mechanical stress and ECM degradation products. Once activated, NF-κB regulates the expression of many cytokines, chemokines, adhesion molecules, inflammatory mediators, and several matrix-degrading enzymes. Therefore, proinflammatory cytokines, their cell surface receptors, NF-κB and downstream signaling pathways are therapeutic targets in OA. This paper critically reviews the recent literature and outlines the potential prophylactic properties of plant-derived phytochemicals such as curcumin and resveratrol for targeting NF-κB signaling and inflammation in OA to determine whether these phytochemicals can be used as functional foods.
first_indexed 2025-11-14T18:19:13Z
format Article
id nottingham-2702
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T18:19:13Z
publishDate 2012
publisher MDPI
recordtype eprints
repository_type Digital Repository
spelling nottingham-27022020-05-04T20:21:43Z https://eprints.nottingham.ac.uk/2702/ Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health Mobasheri, Ali Henrotin, Yves Biesalski, Hans-Konrad Shakibaei, Mehdi Interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) are key cytokines that drive the production of inflammatory mediators and matrix-degrading enzymes in osteoarthritis (OA). These proinflammatory cytokines bind to their respective cell surface receptors and activate inflammatory signaling pathways culminating with the activation of nuclear factor κB (NF-κB), a transcription factor that can be triggered by a host of stress-related stimuli including, excessive mechanical stress and ECM degradation products. Once activated, NF-κB regulates the expression of many cytokines, chemokines, adhesion molecules, inflammatory mediators, and several matrix-degrading enzymes. Therefore, proinflammatory cytokines, their cell surface receptors, NF-κB and downstream signaling pathways are therapeutic targets in OA. This paper critically reviews the recent literature and outlines the potential prophylactic properties of plant-derived phytochemicals such as curcumin and resveratrol for targeting NF-κB signaling and inflammation in OA to determine whether these phytochemicals can be used as functional foods. MDPI 2012-04 Article PeerReviewed Mobasheri, Ali, Henrotin, Yves, Biesalski, Hans-Konrad and Shakibaei, Mehdi (2012) Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health. International Journal of Molecular Sciences, 13 (4). pp. 4202-4232. ISSN 1422-0067 http://www.mdpi.com/1422-0067/13/4/4202 doi:10.3390/ijms13044202 doi:10.3390/ijms13044202
spellingShingle Mobasheri, Ali
Henrotin, Yves
Biesalski, Hans-Konrad
Shakibaei, Mehdi
Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
title Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
title_full Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
title_fullStr Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
title_full_unstemmed Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
title_short Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
title_sort scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
url https://eprints.nottingham.ac.uk/2702/
https://eprints.nottingham.ac.uk/2702/
https://eprints.nottingham.ac.uk/2702/